OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Hematology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	77
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	50
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	26
Hormetic endoplasmic reticulum stress in hematopoietic stem cells	26
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	23
Deficits in our understanding of natural killer cell development in mouse and human	21
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	20
Developmental regulation of primitive erythropoiesis	18
Mechanisms of immunothrombosis in COVID-19	18
Mesenchymal stromal cells: an update	18
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	18
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	18
Disparities in acute myeloid leukemia treatments and outcomes	17
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	17
The impact of obesity-induced inflammation on clonal hematopoiesis	16
Platelet lifespan and mechanisms for clearance	15
Congenital neutropenia: disease models guiding new treatment strategies	15
Unraveling lipid metabolism for acute myeloid leukemia therapy	13
Advances on the genetic basis of red cell membrane disorders	13
Editorial introductions	13
Humanized murine models of platelet function	11
Multifaceted roles of CRISPR technology in blood cancer research	11
High-throughput genotyping tools for red blood cell antigens	10
Editorial introduction	10
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	10

Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	10
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	9
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	9
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	8
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	8
Editorial introductions	8
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	8
Understanding and targeting erythroid progenitor cells for effective cancer therapy	8
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	7
Red blood cell changes due to cancer and cancer treatments: a narrative review	7
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	7
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	7
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	7
Editorial introductions	7
The immunology of PF4 polyanion interactions	6
The state of prediction models in hematologic disease: a worrisome assessment	6
Current Opinion in Hematology	6
Modelling arterial thrombus formation in vitro	6
Translation defects in ribosomopathies	6
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	6
Chediak-Higashi syndrome	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	5
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	5
Models to study myelodysplastic syndrome and acute myeloid leukaemia	5
Editorial introductions	5
Immunomodulatory roles of red blood cells	5
Platelets and platelet–leukocyte interactions in infectious diseases	5
The fulfilled promise and unmet potential of umbilical cord blood	5
Platelet mitochondria: the mighty few	5
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices	5
Editorial introduction	5
Platelet transfusion	5
The congenital dyserythropoieitic anemias: genetics and pathophysiology	5
No time to die? Intrinsic apoptosis signaling in hematopoietic stem and progenitor cells and therapeutic implications	5